Almirall, S.A. (0O9B.IL)
| Previous close | 9.07 |
| Open | 9.03 |
| Bid | 8.80 x 0 |
| Ask | 9.15 x 0 |
| Day's range | 8.99 - 9.07 |
| 52-week range | 7.76 - 9.97 |
| Volume | |
| Avg. volume | 22,510 |
| Market cap | 2.062B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings date | 11 Nov 2024 |
| Forward dividend & yield | 0.18 (2.03%) |
| Ex-dividend date | 12 May 2023 |
| 1y target est | N/A |
Business WireNew Data Show Almirall´s EBGLYSS® (Lebrikizumab) Provided Sustained Disease Control for up to Three Years in More Than 80% of Adults and Adolescents With Moderate-to-severe Atopic Dermatitis
BARCELONA, Spain, September 25, 2024--More than 80 percent of adults and adolescents with moderate-to-severe atopic dermatitis who responded to lebrikizumab treatment at Week 16 in the ADvocate 1 and 2 monotherapy trials and continued treatment for up to three years experienced sustained skin clearance with monthly maintenance dosing. Almirall S.A. (BME: ALM) announced these new long-term results from the ADjoin long-term extension study, which will be presented as a late breaker at the European
Business WireAlmirall to Present New Data on Biologics for Psoriasis and Atopic Dermatitis and Celebrates 80 Years of Innovation at the EADV Congress
BARCELONA, Spain, September 23, 2024--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its participation in the 33rd Congress of the European Academy of Dermatology and Venereology (EADV), taking place in Amsterdam from September 25 to 28, 2024. This year, Almirall marks its 80th anniversary, celebrating eight decades of innovation and commitment to delivering products positively impacting people’s health and lives.
Simply Wall St.Almirall And Two Additional Stocks Considered Below Estimated Market Value
Amidst a complex landscape where global markets display mixed signals, investors are increasingly turning their attention to value and small-cap stocks. This shift comes as major indices like the Dow Jones Industrial Average see notable performance, highlighting a growing divergence from growth stocks which have recently underperformed. In such an environment, identifying undervalued stocks becomes crucial. These are shares that trade below what they are fundamentally worth, offering...
